2023 Q4 Form 10-Q Financial Statement

#000172820523000072 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q4
Revenue -$7.310M $47.13M $0.00
YoY Change
Cost Of Revenue $10.78M $23.36M
YoY Change
Gross Profit -$18.09M $23.76M
YoY Change
Gross Profit Margin 50.43%
Selling, General & Admin $11.53M $11.19M $8.975M
YoY Change 28.42% 53.84% -22.86%
% of Gross Profit 47.07%
Research & Development $261.0K $410.0K $686.7K
YoY Change -61.99% 35.4% -92.32%
% of Gross Profit 1.73%
Depreciation & Amortization $98.00K $60.00K $41.22K
YoY Change 137.75% 182.13% 373.79%
% of Gross Profit 0.25%
Operating Expenses $11.79M $11.66M $9.703M
YoY Change 21.47% 53.48% -52.86%
Operating Profit -$29.87M $15.96M
YoY Change -266.3%
Interest Expense $4.418M $8.000K $321.5K
YoY Change 1274.01% -61.24% -364.84%
% of Operating Profit 0.05%
Other Income/Expense, Net $8.959M
YoY Change -69.82%
Pretax Income -$25.45M $24.90M -$9.382M
YoY Change 171.31% 23.88% -54.69%
Income Tax -$64.00K $2.000M -$283.0K
% Of Pretax Income 8.03%
Net Earnings -$25.39M $22.89M -$10.90M
YoY Change 132.86% 37.36% -48.93%
Net Earnings / Revenue 48.57%
Basic Earnings Per Share $1.19
Diluted Earnings Per Share -$1.32 $1.19 -$0.60
COMMON SHARES
Basic Shares Outstanding 19.21M shares 19.20M shares 18.01M shares
Diluted Shares Outstanding 19.24M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $71.73M $95.00M $99.25M
YoY Change -27.73% -19.21% 53.26%
Cash & Equivalents $71.73M $94.50M $99.25M
Short-Term Investments $484.0K $500.0K
Other Short-Term Assets $3.829M $4.374M $2.612M
YoY Change 46.6% 30.1% 3.87%
Inventory
Prepaid Expenses
Receivables $595.0K $23.28M $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $76.15M $122.2M $101.9M
YoY Change -25.24% 0.99% 52.58%
LONG-TERM ASSETS
Property, Plant & Equipment $127.1M $116.4M $71.54M
YoY Change 77.64% 80.94% 78.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $147.7M $133.0M $95.65M
YoY Change 54.38% 37.39% 62.47%
Other Assets $30.35M $25.73M $18.87M
YoY Change 60.82% 63.61% 313.79%
Total Long-Term Assets $305.1M $275.2M $186.1M
YoY Change 63.98% 55.56% 79.79%
TOTAL ASSETS
Total Short-Term Assets $76.15M $122.2M $101.9M
Total Long-Term Assets $305.1M $275.2M $186.1M
Total Assets $381.3M $397.4M $287.9M
YoY Change 32.42% 33.4% 69.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.75M $34.60M $12.86M
YoY Change -8.61% 1665.87% 918.54%
Accrued Expenses
YoY Change
Deferred Revenue $0.00
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $149.0K $201.0K $425.2K
YoY Change -64.96% -56.17% -44.22%
Total Short-Term Liabilities $41.37M $42.86M $13.41M
YoY Change 208.44% 495.1% 77.63%
LONG-TERM LIABILITIES
Long-Term Debt $14.00K $44.00K $163.4K
YoY Change -91.43% -82.02% -82.12%
Other Long-Term Liabilities $431.0K $1.200M $1.177M
YoY Change -63.37% -0.85%
Total Long-Term Liabilities $445.0K $44.00K $163.4K
YoY Change 172.3% -82.02% -82.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $41.37M $42.86M $13.41M
Total Long-Term Liabilities $445.0K $44.00K $163.4K
Total Liabilities $48.93M $49.30M $17.63M
YoY Change 177.47% 295.31% 108.32%
SHAREHOLDERS EQUITY
Retained Earnings -$126.8M -$102.0M -$105.7M
YoY Change 19.96% 7.59% 14.02%
Common Stock $2.000K $2.000K $1.807K
YoY Change 10.68% 11.17% 13.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $332.3M $348.1M $270.3M
YoY Change
Total Liabilities & Shareholders Equity $381.3M $397.4M $287.9M
YoY Change 32.42% 33.4% 69.12%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q4
OPERATING ACTIVITIES
Net Income -$25.39M $22.89M -$10.90M
YoY Change 132.86% 37.36% -48.93%
Depreciation, Depletion And Amortization $98.00K $60.00K $41.22K
YoY Change 137.75% 182.13% 373.79%
Cash From Operating Activities -$3.833M $25.09M -$4.407M
YoY Change -13.03% -699.15% -75.06%
INVESTING ACTIVITIES
Capital Expenditures $11.74M $16.28M -$10.25M
YoY Change -214.62% 13.13% -18.02%
Acquisitions
YoY Change
Other Investing Activities -$7.105M -$2.540M -$24.25M
YoY Change -70.7% -6.48% -49.38%
Cash From Investing Activities -$18.85M -$18.81M -$14.01M
YoY Change 34.59% 9.96% -76.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -82.00K -530.0K 71.04K
YoY Change -215.43% 250.99% -122.26%
NET CHANGE
Cash From Operating Activities -3.833M 25.09M -4.407M
Cash From Investing Activities -18.85M -18.81M -14.01M
Cash From Financing Activities -82.00K -530.0K 71.04K
Net Change In Cash -22.76M 5.750M -18.34M
YoY Change 24.11% -126.81% -76.61%
FREE CASH FLOW
Cash From Operating Activities -$3.833M $25.09M -$4.407M
Capital Expenditures $11.74M $16.28M -$10.25M
Free Cash Flow -$15.58M $8.810M $5.840M
YoY Change -366.75% -147.42% -212.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q3 pll Exploration And Mine Development Costs
ExplorationAndMineDevelopmentCosts
471000 usd
CY2022Q3 pll Exploration And Mine Development Costs
ExplorationAndMineDevelopmentCosts
434000 usd
pll Exploration And Mine Development Costs
ExplorationAndMineDevelopmentCosts
1668000 usd
pll Exploration And Mine Development Costs
ExplorationAndMineDevelopmentCosts
1485000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3852000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2003000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1565000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6547000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
8000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
21000 usd
us-gaap Interest Expense
InterestExpense
34000 usd
us-gaap Interest Expense
InterestExpense
97000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-22000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-35000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-88000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-60000 usd
CY2023Q3 pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
7958000 usd
CY2022Q3 pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
29367000 usd
pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
15208000 usd
pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
29367000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8959000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29684000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18045000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29583000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19203000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17343000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18081000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19011000 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
22891000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
16665000 usd
us-gaap Net Income Loss
NetIncomeLoss
3613000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2071000 usd
CY2023Q3 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent
-2992000 usd
CY2022Q3 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent
811000 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent
-4084000 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent
662000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2992000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
811000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4084000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
662000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
19899000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17476000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-471000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1409000 usd
CY2023Q3 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent
-264000 usd
CY2022Q3 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent
392000 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent
-830000 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent
392000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94495000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99247000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23281000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
4374000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2612000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
122150000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
101859000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
116422000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71541000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
25734000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18873000 usd
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
133044000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
95648000 usd
CY2023Q3 us-gaap Assets
Assets
397350000 usd
CY2022Q4 us-gaap Assets
Assets
287921000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
34607000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12862000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
201000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
425000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8052000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
124000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
42860000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13411000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
44000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
163000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1174000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1177000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5221000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2881000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
49299000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
17632000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19209000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19209000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18073000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18073000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
459475000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
381242000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-102045000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105658000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9381000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5297000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
348051000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
270289000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
397350000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
287921000 usd
us-gaap Net Income Loss
NetIncomeLoss
3613000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2071000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7378000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2643000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1565000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6547000 usd
pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
15208000 usd
pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
29367000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3170000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3422000 usd
us-gaap Depreciation
Depreciation
174000 usd
us-gaap Depreciation
Depreciation
32000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
169000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
72000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-12000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-27000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-54000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23281000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1633000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
959000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-148000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-69000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
21865000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
270000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
7712000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-2627000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5403000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22041000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
44978000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21892000 usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
6828000 usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
9815000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
28667000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
14087000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80473000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45794000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
71084000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
122059000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
93000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
344000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
973000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
422000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
70318000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
121179000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4752000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
53344000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99247000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64245000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94495000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117589000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5114000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2227000 usd
us-gaap Interest Paid Net
InterestPaidNet
34000 usd
us-gaap Interest Paid Net
InterestPaidNet
97000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
193000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
213000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
270289000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
71084000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1166000 usd
CY2023Q1 us-gaap Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
-2213000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8639000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
331687000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3266000 usd
CY2023Q2 us-gaap Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
1121000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10639000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
325435000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3139000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
422000 usd
CY2023Q3 us-gaap Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
-2992000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
22891000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
348051000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
122059000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-86000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
93000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1350000 usd
CY2022Q3 us-gaap Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
811000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
16665000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
285384000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
10900000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
3139000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1358000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
7576000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets, fair value of stock-based compensation awards, income tax uncertainties, valuation of deferred tax assets, contingent assets and liabilities, legal claims, asset impairments, provisional revenue adjustments, collectability of receivables and environmental remediation. Actual results could differ due to the uncertainty inherent in the nature of these estimates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base our estimates and assumptions on current facts, historical experience, and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from our estimates. To the extent there are material differences between estimates and actual results, future results of operations will be affected.</span></div>
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-102000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105700000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
3715000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
8000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
5000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
859000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3139000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1350000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7571000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2856000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3067000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1260000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7378000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2643000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
72000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
90000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
193000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
213000 usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
3139000 usd
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
1350000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
7571000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
2856000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
265000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
273000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
42000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
136000 shares
CY2023Q1 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
0 shares
CY2022Q1 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
15000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
20000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
307000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
374000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
30000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
59000 shares
CY2023Q2 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
0 shares
CY2022Q2 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
38000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
337000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
395000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q3 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
2000 shares
CY2022Q3 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
37000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
335000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
358000 shares
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
22891000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22891000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
16665000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
16665000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3613000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3613000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3613000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3613000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2071000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2071000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19203000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17966000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18974000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17343000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
36000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
115000 shares
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
37000 shares
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
0 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19239000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18081000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19011000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17343000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.19
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.19
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
391000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
305000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
169000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
474000 shares
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24900000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3400000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3200000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6800000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3400000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1400000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.081
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.17
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.467
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
2.533
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
116681000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
71626000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
259000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
85000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
116422000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71541000 usd
CY2023Q3 pll Equity Method Investments Number
EquityMethodInvestmentsNumber
3 investment
CY2023Q3 pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
8000000 usd
CY2022Q3 pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
29400000 usd
pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
15200000 usd
pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
29400000 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
124040000 usd
CY2023Q3 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
450000 usd
CY2023Q3 pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
7958000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3852000 usd
CY2023Q3 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent
-3256000 usd
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
133044000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
95648000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
28667000 usd
pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
15208000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1565000 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent
-4914000 usd
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
133044000 usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
64234000 usd
CY2022Q3 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
4032000 usd
CY2022Q3 pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
29367000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2003000 usd
CY2022Q3 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent
1203000 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
96833000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
58873000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
14087000 usd
pll Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates
GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates
29367000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6547000 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent
1053000 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
96833000 usd
CY2023Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
458000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
484000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3916000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2128000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
4374000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2612000 usd
CY2023Q3 us-gaap Advances To Affiliate
AdvancesToAffiliate
24031000 usd
CY2022Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
17316000 usd
CY2023Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
256000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
264000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1447000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1293000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
25734000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18873000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
301000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
124000 usd
CY2023Q3 pll Accrued Provisional Revenue Adjustment
AccruedProvisionalRevenueAdjustment
7751000 usd
CY2022Q4 pll Accrued Provisional Revenue Adjustment
AccruedProvisionalRevenueAdjustment
0 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8052000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
124000 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
200000 usd
CY2022Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
600000 usd
CY2023Q3 pll Loss Contingency Number Of Actions Consolidated
LossContingencyNumberOfActionsConsolidated
2 action
CY2023Q2 us-gaap Other Commitment
OtherCommitment
11000000 usd
CY2023Q2 pll Community Development Agreement Parks And Recreation Projects Amount
CommunityDevelopmentAgreementParksAndRecreationProjectsAmount
1000000 usd
CY2023Q3 pll Community Development Agreement Parks And Recreation Projects Payment Amount
CommunityDevelopmentAgreementParksAndRecreationProjectsPaymentAmount
500000 usd
CY2023Q2 pll Community Development Agreement Amount Paid In Annual Installments
CommunityDevelopmentAgreementAmountPaidInAnnualInstallments
10000000 usd
CY2023Q2 pll Community Development Agreement Annual Payment Amount
CommunityDevelopmentAgreementAnnualPaymentAmount
500000 usd
CY2023Q2 pll Community Development Agreement Amount Paid In Annual Installments Period
CommunityDevelopmentAgreementAmountPaidInAnnualInstallmentsPeriod
P20Y
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001728205-23-000072-index-headers.html Edgar Link pending
0001728205-23-000072-index.html Edgar Link pending
0001728205-23-000072.txt Edgar Link pending
0001728205-23-000072-xbrl.zip Edgar Link pending
ex311-10q_q3x2023.htm Edgar Link pending
ex312-10q_q3x2023.htm Edgar Link pending
ex321-10q_q3x2023.htm Edgar Link pending
ex322-10q_q3x2023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pll-20230930.htm Edgar Link pending
pll-20230930.xsd Edgar Link pending
pll-20230930_g1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pll-20230930_pre.xml Edgar Link unprocessable
pll-20230930_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pll-20230930_cal.xml Edgar Link unprocessable
pll-20230930_lab.xml Edgar Link unprocessable
pll-20230930_def.xml Edgar Link unprocessable